SDC1 and cancer: YKL-40 can bind chitin, heparin, collagen, and hyaluronan, and it has been suggested to promote cancer through binding to the IL-13Rα2, RAGE, syndecan-1, and CD44v3 receptors on the surface of cancer cells [7].